Cas:92519-95-4 Viscidulin I manufacturer & supplier

Chemical Name:Viscidulin I

CAS.NO:92519-95-4

Synonyms:2-(2,6-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one;3,5,7,2′,6′-pentahydroxyflavone;Viscidulin I;4H-1-Benzopyran-4-one, 2-(2,6-dihydroxyphenyl)-3,5,7-trihydroxy-

Molecular Formula:C₁₅H₁₀O₇

Molecular Weight:302.236

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:588.3±50.0 °C at 760 mmHg

Density:1.8±0.1 g/cm3

Index of Refraction:1.823

PSA:131.36000

Exact Mass:302.042664

LogP:1.93

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(2,6-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4H-1-Benzopyran-4-one, 2-(2,6-dihydroxyphenyl)-3,5,7-trihydroxy- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2,6-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one Use and application,2-(2,6-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one technical grade,usp/ep/jp grade.

Related News: Australia has started denying entry to all travelers who have come from or transited through mainland China. Viscidulin I manufacturer In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. Viscidulin I supplier The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. Viscidulin I vendor This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them. Viscidulin I factory Australia has started denying entry to all travelers who have come from or transited through mainland China.